Lupin Limited has informed the Exchange regarding the receipt of Establishment Inspection Report (EIR) by the Company from the U.S. FDA for its injectables facility in Nagpur, India, vide Press Release dated December 16, 2025.
Press Release Dec 16 2025
Filed with NSE · · 2 pages · English
Release
Earlier from Lupin
- Press Release Dec 12 2025
- Press Release Dec 05 2025
- Press Release Dec 04 2025
- Press Release Dec 01 2025
- Press Release Nov 28 2025
Later from Lupin
- Press Release Dec 17 2025
- Press Release Dec 18 2025
- Press Release Dec 29 2025
- Lupin Limited Press Release Jan 21 2026
- Press Release Jan 23 2026
Follow Lupin into a list and get an email when it puts out news.
Follow Lupin